SCHEMBL29964443

SCHEMBL29964443

CC(C)(C)OC(=O)N1CCN(c2ccc(-c3cc(-c4cc5c(cc4F)C(=O)NCC5)c(N)nc3F)cc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.39
ALK Q9UM73 2/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
ATR Q13535 1/20 0.37
EGLN2 Q96KS0 1/20 0.37
PDK2 Q15119 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
NAMPT P43490 1/20 0.36
ADORA2A P29274 1/20 0.36
PIK3CA P42336 2/20 0.36
MAP4K4 O95819 1/20 0.36
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
MAPKAPK2 P49137 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964997 0.91 RET (0.40) RETALKSMARCA2SMARCA4PBRM1
SCHEMBL29964553 0.90 SMARCA2 (0.37) ALKSMARCA2SMARCA4PBRM1MAPT
SCHEMBL29963694 0.89 SMARCA2 (0.38) SMARCA2SMARCA4PBRM1PIK3CAMAP4K4
SCHEMBL27160017 0.89 ALOX5 (0.39) RETALKSMARCA2SMARCA4PBRM1
SCHEMBL30816245 0.89 ALOX5 (0.39) RETALKSMARCA2SMARCA4PBRM1
SCHEMBL29964643 0.88 P2RY14 (0.42) RETDDB1CRBNNAMPTGPR119
SCHEMBL29964866 0.87 CHEK2 (0.46) ALKGPR119
SCHEMBL29964810 0.87 SMARCA2 (0.37) SMARCA2SMARCA4PBRM1LMNAPIK3CA
SCHEMBL29965043 0.87 RET (0.39) RETALKSMARCA2SMARCA4PBRM1
SCHEMBL29964221 0.87 GRM1 (0.41) ATRNAMPTENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 RET 889/4885ALK 1520/4885SMARCA2 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.